Logo image of NCNO

NCINO INC (NCNO) Stock Fundamental Analysis

USA - NASDAQ:NCNO - US63947X1019 - Common Stock

25.6 USD
-0.45 (-1.73%)
Last: 10/7/2025, 8:00:01 PM
25.6 USD
0 (0%)
After Hours: 10/7/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, NCNO scores 3 out of 10 in our fundamental rating. NCNO was compared to 281 industry peers in the Software industry. While NCNO seems to be doing ok healthwise, there are quite some concerns on its profitability. NCNO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NCNO was profitable.
NCNO had a positive operating cash flow in the past year.
NCNO had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NCNO reported negative operating cash flow in multiple years.
NCNO Yearly Net Income VS EBIT VS OCF VS FCFNCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

NCNO has a Return On Assets (-2.08%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -3.18%, NCNO is in line with its industry, outperforming 55.87% of the companies in the same industry.
Industry RankSector Rank
ROA -2.08%
ROE -3.18%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
NCNO Yearly ROA, ROE, ROICNCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

NCNO has a worse Gross Margin (60.23%) than 61.92% of its industry peers.
In the last couple of years the Gross Margin of NCNO has grown nicely.
NCNO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
NCNO Yearly Profit, Operating, Gross MarginsNCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NCNO has been increased compared to 1 year ago.
Compared to 5 years ago, NCNO has more shares outstanding
The debt/assets ratio for NCNO is higher compared to a year ago.
NCNO Yearly Shares OutstandingNCNO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NCNO Yearly Total Debt VS Total AssetsNCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.19 indicates that NCNO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.19, NCNO is in line with its industry, outperforming 58.72% of the companies in the same industry.
NCNO has a debt to FCF ratio of 4.28. This is a neutral value as NCNO would need 4.28 years to pay back of all of its debts.
The Debt to FCF ratio of NCNO (4.28) is better than 60.14% of its industry peers.
NCNO has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
NCNO has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 4.28
Altman-Z 3.19
ROIC/WACCN/A
WACC11.3%
NCNO Yearly LT Debt VS Equity VS FCFNCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

NCNO has a Current Ratio of 1.03. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
NCNO's Current ratio of 1.03 is on the low side compared to the rest of the industry. NCNO is outperformed by 70.82% of its industry peers.
A Quick Ratio of 1.03 indicates that NCNO should not have too much problems paying its short term obligations.
NCNO has a Quick ratio of 1.03. This is in the lower half of the industry: NCNO underperforms 69.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
NCNO Yearly Current Assets VS Current LiabilitesNCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

6

3. Growth

3.1 Past

NCNO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.41%.
The Revenue has grown by 13.24% in the past year. This is quite good.
The Revenue has been growing by 31.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)13.24%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.4%

3.2 Future

Based on estimates for the next years, NCNO will show a very strong growth in Earnings Per Share. The EPS will grow by 23.63% on average per year.
Based on estimates for the next years, NCNO will show a quite strong growth in Revenue. The Revenue will grow by 9.50% on average per year.
EPS Next Y21.31%
EPS Next 2Y23.08%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y8.69%
Revenue Next 3Y9.5%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NCNO Yearly Revenue VS EstimatesNCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
NCNO Yearly EPS VS EstimatesNCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.06, which means the current valuation is very expensive for NCNO.
Based on the Price/Earnings ratio, NCNO is valued a bit cheaper than the industry average as 61.92% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.76, NCNO is valued a bit more expensive.
The Price/Forward Earnings ratio is 25.61, which means the current valuation is very expensive for NCNO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NCNO indicates a somewhat cheap valuation: NCNO is cheaper than 66.55% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.21, NCNO is valued at the same level.
Industry RankSector Rank
PE 36.06
Fwd PE 25.61
NCNO Price Earnings VS Forward Price EarningsNCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NCNO.
NCNO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.6
EV/EBITDA 92.89
NCNO Per share dataNCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NCNO's earnings are expected to grow with 23.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.69
PEG (5Y)N/A
EPS Next 2Y23.08%
EPS Next 3Y23.63%

0

5. Dividend

5.1 Amount

No dividends for NCNO!.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (10/7/2025, 8:00:01 PM)

After market: 25.6 0 (0%)

25.6

-0.45 (-1.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)12-04 2025-12-04/amc
Inst Owners116.89%
Inst Owner Change0%
Ins Owners1.44%
Ins Owner Change20.18%
Market Cap2.96B
Analysts73.91
Price Target36.76 (43.59%)
Short Float %10.49%
Short Ratio6.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.43%
Min EPS beat(2)-1.92%
Max EPS beat(2)54.77%
EPS beat(4)2
Avg EPS beat(4)11.18%
Min EPS beat(4)-36.6%
Max EPS beat(4)54.77%
EPS beat(8)6
Avg EPS beat(8)23.5%
EPS beat(12)9
Avg EPS beat(12)17.86%
EPS beat(16)13
Avg EPS beat(16)20.53%
Revenue beat(2)2
Avg Revenue beat(2)1.16%
Min Revenue beat(2)0.4%
Max Revenue beat(2)1.91%
Revenue beat(4)2
Avg Revenue beat(4)-0.07%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)1.91%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)3
Avg Revenue beat(12)-0.38%
Revenue beat(16)7
Avg Revenue beat(16)0.37%
PT rev (1m)0.21%
PT rev (3m)18.72%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)3.59%
EPS NY rev (1m)10.17%
EPS NY rev (3m)9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE 36.06
Fwd PE 25.61
P/S 5.17
P/FCF 49.6
P/OCF 43.72
P/B 2.81
P/tB N/A
EV/EBITDA 92.89
EPS(TTM)0.71
EY2.77%
EPS(NY)1
Fwd EY3.91%
FCF(TTM)0.52
FCFY2.02%
OCF(TTM)0.59
OCFY2.29%
SpS4.95
BVpS9.13
TBVpS-1.43
PEG (NY)1.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.08%
ROE -3.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.23%
FCFM 10.43%
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 4.28
Debt/EBITDA 7.61
Cap/Depr 19.85%
Cap/Sales 1.4%
Interest Coverage N/A
Cash Conversion 203.38%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 3.19
F-Score4
WACC11.3%
ROIC/WACCN/A
Cap/Depr(3y)23.11%
Cap/Depr(5y)36.46%
Cap/Sales(3y)1.95%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y21.31%
EPS Next 2Y23.08%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue 1Y (TTM)13.24%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.4%
Revenue Next Year8.81%
Revenue Next 2Y8.69%
Revenue Next 3Y9.5%
Revenue Next 5YN/A
EBIT growth 1Y73.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.51%
EBIT Next 3Y25.93%
EBIT Next 5YN/A
FCF growth 1Y1158.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y294.96%
OCF growth 3YN/A
OCF growth 5YN/A